SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-007138
Filing Date
2024-02-20
Accepted
2024-02-20 08:57:33
Documents
16
Period of Report
2024-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 55275
2 ex10-11.htm EX-10.11 19622
  Complete submission text file 0001493152-24-007138.txt   302926

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lgst-20240214.xsd EX-101.SCH 3815
4 XBRL DEFINITION FILE lgst-20240214_def.xml EX-101.DEF 26691
5 XBRL LABEL FILE lgst-20240214_lab.xml EX-101.LAB 36844
6 XBRL PRESENTATION FILE lgst-20240214_pre.xml EX-101.PRE 25315
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6014
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41002 | Film No.: 24651041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)